Medical Article

A handful of states have issued guidance documents that illustrate how regulators are viewing the IV hydration and IV therapy businesses, which infusion providers should consider as part of their overall compliance monitoring efforts. The post Infusion Industry Boom Raises Red Flag from State Regulators appeared first on MedCity News.

New tools can predict deadly reactions to common cancer drugs, but adoption lags despite evidence. The post Genetic Screening In Cancer Care: Optimizing Drug Safety And Efficacy Using Personalized Medicine appeared first on MedCity News.

A new study found that continuous glucose monitors can cut healthcare costs by about 20% while also improving outcomes for insulin-dependent diabetes patients, largely by reducing hospitalizations and emergency department visits. Despite these benefits and broad insurance coverage, roughly 80% of eligible patients still are not using the technology — highlighting a significant adoption gap….

A quick conversation about coverage, availability and pricing can help patients make informed decisions. The post The Future of Pharmacy Access: The Impact of Putting Rx Information in Patients’ Hands appeared first on MedCity News.

Concierge and direct primary care models have proven their value as retention tools. Those who view these programs as measurable business assets, not ancillary benefits, will lead the next wave of workforce health innovation. The post From Perk to Infrastructure: How Employers Are Measuring the ROI of Concierge and Direct Primary Care appeared first on…

The solution isn’t about creating more referral pathways, but about building the measurement infrastructure that enables excellent primary care providers to act confidently on their observations.  The post Medicare Mandates Cognitive Screening, But Do PCPs Have the Tools to Act Confidently? appeared first on MedCity News.

Omeros’s complement system drug Yartemlea is now FDA approved for treating a severe and potentially fatal complication of hematopoietic stem cell transplants. Our recap of other regulatory actions includes drug approvals in cancer, rare disease, and metabolic disorders. The post Fatal Complication of Stem Cell Transplants Gets Its First FDA-Approved Therapy appeared first on MedCity…

New research from Mass General Brigham demonstrates that hospital-at-home care can safely deliver comparable outcomes for rural patients — with significant cost savings when patients are transferred home early in their hospital stay. The post Hospital-at-Home Bodes Well for Rural Patients, Research Shows appeared first on MedCity News.

The cruel irony is that incredibly effective treatments already exist. Many people, however, cannot access them due to barriers to care The post A Massive Wave of Eye Disease is Coming, and Healthcare is Unprepared appeared first on MedCity News.